TGF - β Signaling Pathway
Bone Remodeling
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 18, 2026

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Published on: June 13, 2018
1Division of Endocrinology/Metabolism, Neurology and Hematology/Oncology, Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine, Japan. hiroshik@med.kobe-u.ac.jp
Smad3 suppresses osteoblast commitment in mesenchymal stem cells but promotes differentiation and maturation in committed osteoblasts. It enhances mineralization-related gene expression during later stages of osteoblast development.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: